IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496,692 | +10.6% | 10,950 | 0.0% | 0.01% | +22.2% |
| Q2 2023 | $449,279 | +14.8% | 10,950 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $391,353 | -5.4% | 10,950 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $413,582 | +12.1% | 10,950 | +10.0% | 0.01% | 0.0% |
| Q2 2022 | $369,000 | 0.0% | 9,956 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $369,000 | +21.8% | 9,956 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $303,000 | -9.8% | 9,956 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $336,000 | -14.3% | 9,956 | 0.0% | 0.01% | -23.1% |
| Q2 2021 | $392,000 | -12.5% | 9,956 | 0.0% | 0.01% | -18.8% |
| Q1 2021 | $448,000 | – | 9,956 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |